✦ LIBER ✦

Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes: Focus On Sitagliptin

✍ Scribed by Herman, G A; Stein, P P; Thornberry, N A; Wagner, J A

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dipeptidyl Peptidase-4 Inhibitors for th

✍ Dr. Joshua J. Neumiller; Dr. Lindy Wood; Mr. R. Keith Campbell 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 394 KB

The asymmetric synthesis of Sitagliptin,

✍ Liu, Feng (author);Yu, Wansheng (author);Ou, Wenhua (author);Wang, Xiaoke (autho 📂 Article 📅 2010 🏛 Scientific Reviews Ltd. 🌐 English ⚖ 141 KB

The asymmetric synthesis of Sitagliptin,

✍ Liu, Feng (author);Yu, Wansheng (author);Ou, Wenhua (author);Wang, Xiaoke (autho 📂 Article 📅 2010 🏛 Scientific Reviews Ltd. 🌐 English ⚖ 141 KB

EFFECT OF THE DIPEPTIDYL PEPTIDASE-4 INH

✍ Sara Stafford; Dariush Elahi; Graydon S. Meneilly 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Saxagliptin: a new dipeptidyl peptidase-

✍ Carolyn F. Deacon; Jens J. Holst 📂 Article 📅 2009 🏛 Springer Healthcare Communications 🌐 English ⚖ 223 KB

Dipeptidyl peptidase-4 inhibitors in the

✍ C. F. Deacon 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 711 KB